REPLIGEN CORP - COMMON STOCK (RGEN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
RGEN on Nasdaq
Type / Class
Equity / COMMON STOCK
Shares outstanding
56.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
59.8M
Holdings value
$8B
% of all portfolios
0.008%
Grand Portfolio weight change
+0%
Number of holders
444
Number of buys
231
Number of sells
-214
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REPLIGEN CORP - COMMON STOCK (RGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.3% $725M 5.2M BlackRock, Inc. 31 Mar 2025
PRICE T ROWE ASSOCIATES INC /MD/ 6.1% -50.8% $436M -$471M 3.43M -51.9% T. Rowe Price Associates, Inc. 31 Aug 2025
EDDLEMAN ROY T 4.84% $377M 2.71M Roy T. Eddleman Living Trust 31 Dec 2024

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 59.8M $8B +$241M $133.67 444
2025 Q2 58M $7.22B +$69.1M $124.38 442
2025 Q1 57.4M $7.3B +$139M $127.24 438
2024 Q4 56.2M $8.09B +$106M $143.94 427
2024 Q3 55.5M $8.25B +$30.3M $148.82 439
2024 Q2 56M $7.06B -$124M $126.06 443
2024 Q1 56.3M $10.3B -$351M $183.92 480
2023 Q4 58.1M $10.4B +$203M $179.80 463
2023 Q3 57.1M $9.08B +$389M $159.01 435
2023 Q2 54.7M $7.74B +$95.6M $141.46 441
2023 Q1 53.8M $9.05B +$70.9M $168.36 442
2022 Q4 53.5M $9.06B +$400M $169.31 436
2022 Q3 51M $9.56B +$146M $187.11 424
2022 Q2 50.3M $8.17B +$277M $162.40 391
2022 Q1 48.7M $9.15B +$201M $188.09 431
2021 Q4 47.1M $12.5B -$237M $264.84 488
2021 Q3 47.2M $13.6B +$286M $288.99 472
2021 Q2 46.3M $9.25B +$157M $199.62 421
2021 Q1 45.7M $8.87B +$76.9M $194.41 453
2020 Q4 45.8M $8.77B +$267M $191.63 444
2020 Q3 44.7M $6.6B -$40.2M $147.54 384
2020 Q2 45.1M $5.58B -$187M $123.61 363
2020 Q1 46.5M $4.48B +$298M $96.54 301
2019 Q4 43.5M $4.03B -$117M $92.50 296
2019 Q3 44.8M $3.43B -$8.49M $76.69 295
2019 Q2 44.7M $3.84B +$502M $85.95 264
2019 Q1 40.2M $2.38B +$32M $59.08 241
2018 Q4 39.8M $2.1B -$117M $52.74 237
2018 Q3 41.8M $2.32B +$69.4M $55.46 196
2018 Q2 40.6M $1.91B +$107M $47.04 188
2018 Q1 38.6M $1.4B +$29.2M $36.18 181
2017 Q4 37.9M $1.37B +$48.5M $36.28 178
2017 Q3 36.4M $1.4B +$28.8M $38.32 187
2017 Q2 35.6M $1.47B +$152M $41.44 197
2017 Q1 32.5M $1.14B +$158M $35.20 179
2016 Q4 32.3M $995M +$13.4M $30.82 180
2016 Q3 31.9M $963M +$47.8M $30.19 177
2016 Q2 30.4M $833M +$19.4M $27.36 181
2016 Q1 29.6M $794M +$36.1M $26.82 180
2015 Q4 28.5M $807M -$43.3M $28.29 173
2015 Q3 30.1M $838M -$17.5M $27.85 183
2015 Q2 30.3M $1.25B +$37.4M $41.27 173
2015 Q1 29.6M $898M +$24.9M $30.36 166
2014 Q4 28.9M $571M +$24.8M $19.80 158
2014 Q3 28.1M $560M -$3.58M $19.91 162
2014 Q2 28.1M $641M +$57M $22.79 162
2014 Q1 26.2M $337M +$13.1M $12.86 132